e-learning
resources
Stockholm 2007
Monday 17.09.2007
Changing practice with anti-IgE: patient, physician and payor perspectives
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evidence into practice: moving forward with anti-IgE
M. Humbert (Clamart, France)
Source:
Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Session:
Changing practice with anti-IgE: patient, physician and payor perspectives
Session type:
Evening Symposium
Number:
2846
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Humbert (Clamart, France). Evidence into practice: moving forward with anti-IgE. Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Telemonitoring in clinical practice: a way forward?
Source: Annual Congress 2013 –Primary Care Programme "Asthma management in clinical practice"
Year: 2013
Moving forward from drug-centred to patient-centred research
Source: Eur Respir J, 53 (2) 1801870; 10.1183/13993003.01870-2018
Year: 2019
Application of management guidelines to the assessment of new medicines: driving us forward or holding us back?
Source: Eur Respir J 2004; 23: 793-794
Year: 2004
Is our approach to basic research right? Pitfalls and successes: what is the way forward?
Source: ERS Research Seminar 2016
Year: 2016
Anti-IgE therapy: current knowledge and future perspective
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019
Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward
Source: Eur Respir J 2013; 42: 1446-1448
Year: 2013
Anti-IgE: changing lives in clinical practice?
Source: Eur Respir Rev 2007; 16: 59-60
Year: 2007
Personalised medicine: a step forward to better care?
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013
Omalizumab in practice: learning from experience
Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Year: 2007
Evaluating response to omalizumab (anti-IgE) in clinical practice
Source: Eur Respir J 2005; 26: Suppl. 49, 48s
Year: 2005
Nurse prescribing in COPD - The way forward
Source: Eur Respir J 2002; 20: Suppl. 38, 621s
Year: 2002
EASE: major outcomes and lessons going forward
Source: Annual Congress 2010 - Clinical Trials: "EURO VENT - endobronchial valves in heterogeneous emphysema patients", "EASE - randomized trial of airway bypass in homogeneous emphysema"
Year: 2010
The way forward: how to link real-life situations and clinical trial results
Source: Annual Congress 2013 - Lunchtime Session "Tiotropium soft mist inhaler and mortality in COPD: results of the TIOSPIR clinical trial"
Year: 2013
Current practice and future directions in CSA treatment: positive airway pressure, stimulation and pharmacotherapy
Source: Sleep and Breathing Conference 2021
Year: 2021
Eosinophils are out of fashion: the only way forward is to target the neutrophils
Source: International Congress 2016 – Childhood wheeze: are we making any progress?
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept